Overview

Fullscript runs a two-sided digital health platform connecting health practitioners with patients to create, manage, and dispense supplement plans. Practitioners use the platform to build personalized protocols, track patient progress, send reminders, and access educational resources to support behavior change. Supplements are sold directly to patients or in-office, with practitioner-set pricing, enabling more affordable care. The system also provides patient-facing materials, infographics, whitepapers, and a wealth of blog content to support adherence and education. Compared with competitors, Fullscript leverages a large practitioner network (over 70,000 users) and combines dispensing capabilities with comprehensive educational and adherence tools, all aimed at streamlining practitioners’ workflows. The company’s goal is to improve patient outcomes by making supplement planning, dispensing, and adherence easier and more affordable for both practitioners and patients.

Simplify's Take

What believers are saying

• HGGC and Snapdragon expanded investment in 2026 provides liquidity and growth capital.
• 3X4 Genetics partnership on Oct 29, 2024 enhances nutrigenomics in supplement plans.
• InShapeMD partnership on Sep 4, 2025 offers 10% patient discounts on supplements.

What critics are saying

• Rupa acquisition causes talent exodus to Labcorp, halting Fullscript Labs in 6-9 months.
• Thorne Research undercuts Fullscript margins 15-20% via ThornePro portal in 12-18 months.
• FDA cracks down on Journeys AI protocols, triggering takedowns in 3-6 months.

What makes Fullscript unique

• Fullscript Journeys integrates lab testing, AI interpretations, and personalized supplements for 125,000 providers.
• FS Assist leverages 13,600 hours of validated clinical logic for practitioner-centered care plans.
• Rupa Health acquisition adds management of 3,000+ lab tests to whole person care platform.

Help us improve and share your feedback! Did you find this helpful?

YesNo